Abstract Current study is conducted to evaluate method verification of two locally available kits manufactured by DSI & BIORAD for quantitative estimation of Hepatitis B virus antibodies in human normal immunoglobulin by using International standard of National Institute of Biological Standards and Control. Four analyst perform five sets of test in duplicate analysing accuracy, precision, and limit of detection, sensitivity and specificity. Our results suggest that both DSI and BIORAD kits fulfil the validation criteria and are sensitive to detect up to 10 mIU concentration precisely and accurately. DSI kit is more precise at concentration 100 mIU and economically 4-5 times cheaper in local market; on the other hand, BIORAD kits provide larger detection range up to 1000 mIU.
Human normal immunoglobulin is human pooled plasma derived therapeutic preparation which contains mainly human immunoglobulin IgG intended to use for the treatment of primary/secondary immune deficiencies [1] , autoimmune diseases [2] , various haematological, neurological disorder and acute infections. These commercially available human normal immunoglobulin (HNI) and specific immunoglobulin (SI) intravenous (IV) or intramuscular (IM) preparation leads to neutralization of a wide range of antigens including pathogens and super antigens [3] . Almost all the plasma derived products like albumin, blood coagulation factors, immunoglobulin are prepared by Cohn cold ethanol fractionation method or combination with liquid chromatography [4, 5] Frozen plasma is thawed at 4°C and cryoprecipitate is first extracted from plasma for preparation of factor VIII concentrate and the supernatant of the cryoprecipitate contains fractions FI, FII and FIII used for the production of IgG (ref) IV or IM administration. In addition, 'specific' immunoglobulin are preparations that prepared from high titres plasma of particular antibodies, e.g. anti-D, anti-tetanus, etc. [6, 7] . To avoid any adverse effects in recipients of these products, quality control of these plasma derived products as per Pharmacopial monographs by regulatory laboratory is mandatory. Antibodies to HBs Ag is one of the critical parameter for HNI IV/IM and SI must contain at least 0.5 IU/gm or more antibodies to HBs Ag to provide protection against any possible chance of Hepatitis B virus (HBV) infection. Any individual having serum levels of Anti-HBs Ag level C10 mIU/mL is considered immune against HBV and less than that of anti-HBs Ag more susceptibility to HBV infection. During immune deficient stage, hospitalised patients are more prone to HBV infection and for avoiding such condition, human indented preparation of HNI and SI are prescribed to contain the stated value of antibodies to HBV. Currently available Anti-HBs ELISA kits are meant for in vitro quantitative detection of antibodies to hepatitis B virus surface antigen (anti-HBsAg) in clinical samples mainly for assessing antibody response levels to HBsAg-vaccine but currently no kit is available which is specific for estimation of antibodies against HBV in HNI and SI preparation. So current study is conducted in our laboratory to evaluate performance verification of two kits available with local vender DSI (DS-EIA-Anti HBs AG) and BIO RAD (MONALISA Anti HBs Plus) anti-HBsAg IgG/Ig. 
Materials and Methods

Discussion
In our current study, results show that DSI kit has better regression coefficient than BIORAD kit and both show significant difference at P \ 0.05, this may be due to higher range of calibrators in BIORAD kit system 10, 100, 400, 1000 mIU and in DSI kit is 10, 50, 100, 150 mIU, and same is confirmed recalculating the standard graph of BIORAD kit by eliminating calibrator concentration 1000 mIU in standard curve then mean regression coefficient of twenty tests by BIORAD kit is more than 0.999 ± 0.01. Further analysis of our data also shows that, both the methods are equally precise and accurate for measuring Human antibodies to HBV antigen in HNI at concentration levels 25, 50, 125 mIU all the results are within ±2 SD, but at concentration level 100 mIU NIBSC standard, DSI kit shows more precision in analysis than the BIORAD kit all results are within ±1 SD as shown in Fig. 1 . On analysing, the spike recovery study in both the kits show mean % recovery more than 98.0 % and BIORAD kits have edge in accuracy over DSI kit as shown in Table 1 , but results are more precise in DSI kit as shown in Fig. 1 . Our study shows that both the kits available in market are suitable for quantitative estimation of HBV antibodies in NHI and SI preparation, and can measure up to 10 mIU/ml Values are shown in mean, SD and coefficient of variation (CV) for n = 20. Unpaired t test. ** Significantly different (P \ 0.05) and ns non-significant accurately and precisely. DSI kit is economical around 4-5 times cheaper in local market than BIORAD but BIORAD kits can measure up to 10-1000 mIU concentration compared to DSI kit which is up to 10-150 mIU.
Conclusion
In comparison of both the locally available kits DSI and BIORAD can effectively be used for measurement of HBs Ag antibodies in normal human immunoglobulin and specific immunoglobulin. DSI kit is more precise and more economical than BIORAD kits. BIORAD kits are suitable for larger range of detection in single run. code: 07/164 at concentration a 25 mIU/ml, b 50 mIU/ml, c 100 mIU/ml, d 125 mIU/ml, and e 150 mIU/ml, f showing recovery studies of 10 mIU/ml
